Halozyme Therapeutics
HALO
₹5,520
Share price
0.78%
Change (1 day)
63.38%
Change (1 year)
Categories
Halozyme Therapeutics (HALO) - Cash on Hand
Cash on Hand as of December 2024 : ₹50.99 Billion
According to Halozyme Therapeutics's latest financial reports the company has ₹50.99 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | ₹51.13 B | 82.81% |
| 2023-12-31 | ₹27.97 B | -6.83% |
| 2022-12-31 | ₹30.02 B | -45.56% |
| 2021-12-31 | ₹55.14 B | 104.9% |
| 2020-12-31 | ₹26.91 B | -10.41% |
| 2019-12-31 | ₹30.04 B | 21.18% |
| 2018-12-31 | ₹24.78 B | -17.26% |
| 2017-12-31 | ₹29.95 B | 115.08% |
| 2016-12-31 | ₹13.92 B | 93.47% |
| 2015-12-31 | ₹7.19 B | -16.24% |
| 2014-12-31 | ₹8.59 B | 94.58% |
| 2013-12-31 | ₹4.41 B | -18.92% |
| 2012-12-31 | ₹5.44 B | 94.96% |
| 2011-12-31 | ₹2.79 B | -25.1% |
| 2010-12-31 | ₹3.73 B | 19.18% |
| 2009-12-31 | ₹3.13 B | 2.22% |
| 2008-12-31 | ₹3.06 B | -20.11% |
| 2007-12-31 | ₹3.83 B | 95.87% |
| 2006-12-31 | ₹1.95 B | 127.32% |
| 2005-12-31 | ₹0.86 B | 24.19% |
| 2004-12-31 | ₹0.69 B | 2923.65% |
| 2003-12-31 | ₹22.92 M | 391.64% |
| 2002-12-31 | ₹4.66 M | 269.93% |
| 2001-12-31 | ₹1.26 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | ₹16.87 B | -66.91% | 🇺🇸 USA |
 | ₹292.88 B | 474.29% | 🇺🇸 USA |
 | ₹150.92 B | 195.94% | 🇺🇸 USA |
 | ₹1.751 T | 3,335.31% | 🇺🇸 USA |
 | ₹705.77 B | 1,283.88% | 🇫🇷 France |
 | ₹2.098 T | 4,013.92% | 🇺🇸 USA |